Skip to content
10-Q

Quarterly Report

CONSTELLATION PHARMACEUTICALS INC

0001564590-20-036390

← back to feed
Filed
Aug 5, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Jul 31, 2020 47.5M sh
Capex Q2 2020 · Jun 30, 2020 $161K
Capex Q2 2020 · Jun 30, 2019 $469K
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$47.06M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$36.18M
Long Term Debt Q2 2020 · Jun 30, 2020 $27.57M
Long Term Debt Q2 2020 · Dec 31, 2019 $29.64M
Short Term Debt Q2 2020 · Jun 30, 2020 $2.15M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $179.11M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $334.33M
Stockholders Equity Q2 2020 · Jun 30, 2020 $471.98M
Stockholders Equity Q2 2020 · Mar 31, 2020 $315.53M
Stockholders Equity Q2 2020 · Dec 31, 2019 $337.58M
Stockholders Equity Q2 2020 · Jun 30, 2019 $67.18M
Stockholders Equity Q2 2020 · Mar 31, 2019 $86.08M
Stockholders Equity Q2 2020 · Dec 31, 2018 $104.16M
Current Liabilities Q2 2020 · Jun 30, 2020 $27.28M
Current Liabilities Q2 2020 · Dec 31, 2019 $22.76M
Total Liabilities Q2 2020 · Jun 30, 2020 $62.82M
Total Liabilities Q2 2020 · Dec 31, 2019 $61.55M
Current Assets Q2 2020 · Jun 30, 2020 $523.1M
Current Assets Q2 2020 · Dec 31, 2019 $386.99M
Total Assets Q2 2020 · Jun 30, 2020 $534.8M
Total Assets Q2 2020 · Dec 31, 2019 $399.13M
Sga Expense Q2 2020 · Jun 30, 2020 $6.96M
Sga Expense Q2 2020 · Jun 30, 2020 $12.87M
Sga Expense Q2 2020 · Jun 30, 2019 $4.89M
Sga Expense Q2 2020 · Jun 30, 2019 $9.32M
Rd Expense Q2 2020 · Jun 30, 2020 $22.63M
Rd Expense Q2 2020 · Jun 30, 2020 $42.7M
Rd Expense Q2 2020 · Jun 30, 2019 $15.96M
Rd Expense Q2 2020 · Jun 30, 2019 $31.63M
Net Income Q2 2020 · Jun 30, 2020 −$29.75M
Net Income Q2 2020 · Jun 30, 2020 −$55.2M
Net Income Q2 2020 · Mar 31, 2020 −$25.44M
Net Income Q2 2020 · Dec 31, 2019 −$85.6M
Net Income Q2 2020 · Jun 30, 2019 −$20.77M
Net Income Q2 2020 · Jun 30, 2019 −$40.19M
Net Income Q2 2020 · Mar 31, 2019 −$19.43M
Operating Income Q2 2020 · Jun 30, 2020 −$29.59M
Operating Income Q2 2020 · Jun 30, 2020 −$55.57M
Operating Income Q2 2020 · Jun 30, 2019 −$20.84M
Operating Income Q2 2020 · Jun 30, 2019 −$40.95M